Metoprolol succinate
Metoprolol succinate is one of 8,063 medications in the MedPlain dataset. Key details — Brand name: Metoprolol succinate; Generic name: METOPROLOL SUCCINATE; Manufacturer: Oryza pharmaceuticals Inc..
| Brand name | Metoprolol succinate |
|---|---|
| Generic name | METOPROLOL SUCCINATE |
| Manufacturer | Oryza pharmaceuticals Inc. |
| Used for | 1 INDICATIONS AND USAGE Metoprolol succinate, is a beta-adrenergic blocker indicated for the treatment of: Hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and non-fatal cardiovascular events, primarily strokes and myocardial infarctions. ( 1.1 ) Angina Pectoris. ( 1.2 ) Heart Failure, to reduce the risk of cardiovascular mortality and heart failure hospitalizations in patients with heart failure ( 1.3 ) 1.1 Hypertension Metoprolol succinate extended-release tablets are indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure lowers the risk of fatal and non-fatal cardiovascular events, primarily strokes and myocard |
| Dosage | 2 DOSAGE AND ADMINISTRATION Administer once daily. Titrate at weekly or longer intervals as needed and tolerated. ( 2 ) Hypertension: Starting dose is 25 to 100 mg. ( 2.1 ) Angina Pectoris: Starting dose is 100 mg. ( 2.2 ) Heart Failure: Starting dose is 12.5 or 25 mg. ( 2.3 ) Switching from immediate-release metoprolol to extended-release metoprolol succinate: use the same total daily dose of metoprolol succinate extended-release tablets. ( 2 ) 2.1 Hypertension Adults: The usual initial dosage |
| Active ingredient(s) | METOPROLOL SUCCINATE |
| Route | ORAL |
| Official label | https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=151079c5-6360-45ed-8118-885543d6a4ad |